Drug/Drug Interactions and the Delivery of Drugs to their Site of Action

Abstract

Get full access to this article

View all access options for this article.

References

Morrelli

H. F.

Melmon

K. L.

: The Clinician's Approach to Drug Interactions. Calif. Med. 109: 380–389, 1968.

Prescott

L. F.

: Pharmacokinetic Drug Interactions. Lancet 2: 1239–1243, 1969.

Koch-Weser

Sellers

E. M.

: Drug Interactions with Coumarin Anticoagulants. New Eng. J. Med. 285:487–498, 547–558, 1971.

Solomon

H. M.

: In Advances in Internal Medicine, 16 Year Book Publishers, Inc., 1970, p. 285.

Harris

P. A.

Riegelman

: Influence of the Route of Administration on the Area under the Plasma Concentration-Time Curve. J. Pharm. Sci. 58: 71–75, 1969.

Barr

W. H.

: Factors Involved in the Assessment of Systemic or Biologic Availability of Drug Products. Drug Information Bull. 3: 27–45, 1969.

Boyes

R. N.

Adams

H. J.

Duce

B. R.

: Oral Absorption and Disposition Kinetics of Lidocaine Hydrochloride in Dogs. J. Pharmacol. Exp. Ther. 174: 1–8, 1970.

Shand

D. G.

Nuckolls

E. M.

Oates

J. A.

: Plasma Propranolol Levels in Adults. Clin. Pharmacol. Ther. 11: 112–120, 1970.

Gibaldi

Boyes

R. N.

Feldman

: Influence of First-Pass Effect on Availability of Drugs on Oral Administration. J. Pharm. Sci. 60: 1338–1340, 1971.

10.

Rowland

: Influence of Route of Administration on Drug Availability. J. Pharm. Sci. 61: 70–74, 1972.

11.

Bradley, In Handbook of Physiology, Sec. II, Vol. II, Wilkins Co., Baltimore, 1963, p. 1387.

12.

Wagner

J. G.

Northam

J. I.

Alway

C. D.

Carpenter

O. S.

: Blood Levels of Drug at the Equilibrium State after Multiple Dosing. Nature 207: 1301–1302, 1965.

13.

Paterson

J. W.

Conolly

M. E.

Dollery

C. T.

Hayes

Cooper

R. G.

: The Pharmacodynamics and Metabolism of Propranolol in Man. Pharmacologia Clinica, 2: 127, 1970.

14.

Cleveland

C. R.

Shand

D. G.

: Effect of route administration on the relationship between beta-adrenergic blockade and plasma propranolol level. Clin. Pharmacol. Ther. 13: 181–185, 1972.

15.

Vesell

E. S.

Passananti

G. T.

Greene

F. E.

Page

J. G.

: Drug Metabolism in Man. Genetic control of drug levels of the induction of drug-metabolizing enzymes in man: Individual variability in the extent of allopurinol and nortriptyline inhibition of drug metabolism. Ann. N. Y. Acad. Sci. 179: 752–773, 1971.

16.

Kolmodin

Azarnoff

D. L.

Sjoqvist

: Effect of Environmental Factors on Drug Metabolism: Decreased Plasma Half-life of Antipyrine in Workers Exposed to Chlorinated Hydrocarbon Insecticides. Clin. Pharmacol. Ther. 10: 638–642, 1969.

17.

Davies

D. S.

Thorgeirsson

S. S.

: Drug Metabolism in Man: Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man. Ann. N. Y. Acad. Sci. 179: 411–420, 1971.

18.

Hunninghake

D. B.

Azarnoff

D. L.

: Drug Interactions with Warfarin. Arch. Int. Med. 121: 349–352, 1968.

19.

Hoogland

D. R.

Miya

T. S.

Bousquet

W. F.

: Metabolism and Tolerance Studies with Chlordiazepoxide-2-¹⁴C in the Rat. Toxic. Appl. Pharmacol. 9: 116–123, 1966.

20.

Udall

J. A.

: Warfarin Therapy Not Influenced by Meprobamate, A Controlled Study in Nine Men. Curr. Ther. Res. 12:724–728 (November) 1970.

21.

Solomon

H. M.

Barakat

M. J.

Ashley

C. J.

: Mechanisms of Drug Interactions, J. A. M. A. 216: 1997–1999, 1971.

22.

McAllister

R. G.

Shand

D. G.

Oates

J. A.

: Unpublished observations.

23.

Welch

R. M.

Harrison

Y. E.

Conney

A. H.

Burns

J. J.

: An Experimental Model in Dogs for Studying Interactions of Drugs with Bishydroxycoumarin. Clin. Pharmacol. Ther. 10: 817–825, 1969.

24.

Remmer

: The Role of the Liver in Drug Metabolism. Amer. J. Med. 49: 617–629, 1970.

25.

Thomson

P. D.

Rowland

Melmon

: The Influence of Heart Failure, Liver Disease, and Renal Failure on the Disposition of Lidocaine in Man. Amer. Heart J. 82: 417–421, 1971.

26.

Whitsett

T. L.

Dayton

P. G.

McNay

J. L.

: The Effect of Hepatic Blood Flow on the Hepatic Removal Rate of Oxyphenbutazone in the Dog. J. Pharm. Exp. Ther. 177: 246–255, 1971.

27.

Ohnhaus

E. E.

Thorgeirsson

S. S.

Davies

D. S.

Breckenridge

: Changes in Liver Blood Flow During Enzyme Induction. Biochem. Pharmacol. 20: 2561–2570, 1971.

28.

Clinicopathologic Conference: Hypertension and the Lupas Syndrome. Amer. J. Med. 49: 519–528, 1970.

29.

Nies

A. S.

Oates

J. A.

: Clinicopathologic Conference: Hypertension and the Lupas Syndrome - Revisited. Amer. J. Med. 51: 812–817, 1971.

Drug/Drug Interactions and the Delivery of Drugs to their Site of Action—Important Clinical Aspects

Abstract

Get full access to this article

References